Survey of TREATments for Diabetic Macular Edema (STREAT-DME) Study
Not Applicable
- Conditions
- Diabetic Macular Edema
- Registration Number
- JPRN-UMIN000023160
- Lead Sponsor
- J-CRERST organization
- Brief Summary
DME with anti-VEGF monotherapy or without anti-VEGF during the clinical course showed better results, in contrast DME with combination therapy showed worse. From this real-world data, the greater improvement of VA was obtained in a 2-year treatment course of DME dependent on the more recent starting year of intervention. Also, the proportion of eyes treated with anti-VEGF drug increased over time, which may be related to the better prognosis of VA after intervention.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1552
Inclusion Criteria
Not provided
Exclusion Criteria
Ocular disease other than diabetic macular edema diabetic macular edema associated with severe systemic disorders
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of visual acuity and morphological resolution of edema within 2 years of clinical course since initial intervention
- Secondary Outcome Measures
Name Time Method % of each intervention and averaged number of each intervention